Gland Pharma Ltd.'s market cap is currently ₹318.91B. The company's EPS TTM is ₹13.08; its P/E ratio is 41.40; and it has a dividend yield of 0.94%. Gland Pharma Ltd. is scheduled to report earnings on August 5, 2025, and the estimated EPS forecast is ₹13.67. See an overview of income statement, balance sheet, and cash flow financials.
